Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes

Abstract

Co-occurring mutations in the NOTCH and HR pathways are associated with increased efficacy of immunotherapy in advanced NSCLC. This genomic predictor deserves further investigation to fully assess its potential in informing therapeutic decisions.